158 related articles for article (PubMed ID: 29492602)
1. Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer.
Rombouts SJE; Derksen TC; Nio CY; van Hillegersberg R; van Santvoort HC; Walma MS; Molenaar IQ; van Leeuwen MS
Abdom Radiol (NY); 2018 Oct; 43(10):2702-2711. PubMed ID: 29492602
[TBL] [Abstract][Full Text] [Related]
2. Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study.
Fegrachi S; Walma MS; de Vries JJJ; van Santvoort HC; Besselink MG; von Asmuth EG; van Leeuwen MS; Borel Rinkes IH; Bruijnen RC; de Hingh IH; Klaase JM; Molenaar IQ; van Hillegersberg R
Eur J Surg Oncol; 2019 Nov; 45(11):2166-2172. PubMed ID: 31227340
[TBL] [Abstract][Full Text] [Related]
3. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer.
Scopelliti F; Pea A; Conigliaro R; Butturini G; Frigerio I; Regi P; Giardino A; Bertani H; Paini M; Pederzoli P; Girelli R
Surg Endosc; 2018 Sep; 32(9):4022-4028. PubMed ID: 29766302
[TBL] [Abstract][Full Text] [Related]
4. [Radiofrequency ablation of pancreatic neuroendocrine tumor].
Hlavsa J; Procházka V; Kala Z; Man M; Andrasina T; Cíhalová M; Válek V; Crha M; Svobodová I; Urbanová L
Klin Onkol; 2011; 24(3):209-15. PubMed ID: 21717790
[TBL] [Abstract][Full Text] [Related]
5. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results.
D'Onofrio M; Crosara S; De Robertis R; Butturini G; Salvia R; Paiella S; Bassi C; Mucelli RP
Technol Cancer Res Treat; 2017 Jun; 16(3):285-294. PubMed ID: 27193941
[TBL] [Abstract][Full Text] [Related]
7. Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial.
Frigerio I; Paiella S; Barbi E; Bianco R; Boz G; Butturini G; Cantore M; Cardarelli N; Mirko D; Fiorentini G; Giardino A; Lionetto G; Malleo G; Mambrini A; Milella M; Passardi A; Regi P; Salvia R; Scopelliti F; Viviani E; Bassi C; Girelli R
Pancreatology; 2021 Oct; 21(7):1342-1348. PubMed ID: 34215498
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial.
Walma MS; Rombouts SJ; Brada LJH; Borel Rinkes IH; Bosscha K; Bruijnen RC; Busch OR; Creemers GJ; Daams F; van Dam RM; van Delden OM; Festen S; Ghorbani P; de Groot DJ; de Groot JWB; Haj Mohammad N; van Hillegersberg R; de Hingh IH; D'Hondt M; Kerver ED; van Leeuwen MS; Liem MS; van Lienden KP; Los M; de Meijer VE; Meijerink MR; Mekenkamp LJ; Nio CY; Oulad Abdennabi I; Pando E; Patijn GA; Polée MB; Pruijt JF; Roeyen G; Ropela JA; Stommel MWJ; de Vos-Geelen J; de Vries JJ; van der Waal EM; Wessels FJ; Wilmink JW; van Santvoort HC; Besselink MG; Molenaar IQ;
Trials; 2021 Apr; 22(1):313. PubMed ID: 33926539
[TBL] [Abstract][Full Text] [Related]
9. US-Guided Percutaneous Radiofrequency Ablation of Locally Advanced Pancreatic Adenocarcinoma: A 5-Year High-Volume Center Experience.
D'Onofrio M; Beleù A; Sarno A; De Robertis R; Paiella S; Viviani E; Frigerio I; Girelli R; Salvia R; Bassi C
Ultraschall Med; 2022 Aug; 43(4):380-386. PubMed ID: 32797463
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients.
Paiella S; Malleo G; Cataldo I; Gasparini C; De Pastena M; De Marchi G; Marchegiani G; Rusev B; Scarpa A; Girelli R; Giardino A; Frigerio I; D'Onofrio M; Secchettin E; Bassi C; Salvia R
Langenbecks Arch Surg; 2018 Mar; 403(2):213-220. PubMed ID: 28983662
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic ultrasound-guided radiofrequency ablation for management of benign solid pancreatic tumors.
Choi JH; Seo DW; Song TJ; Park DH; Lee SS; Lee SK; Kim MH
Endoscopy; 2018 Nov; 50(11):1099-1104. PubMed ID: 29727904
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation of the pancreas: two-week follow-up in a porcine model.
Fegrachi S; Molenaar IQ; Klaessens JH; Besselink MG; Offerhaus JA; van Hillegersberg R
Eur J Surg Oncol; 2014 Aug; 40(8):1000-7. PubMed ID: 24286809
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review.
Fegrachi S; Besselink MG; van Santvoort HC; van Hillegersberg R; Molenaar IQ
HPB (Oxford); 2014 Feb; 16(2):119-23. PubMed ID: 23600801
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
16. Role of dual-energy computed tomography in detecting early recurrences of lung tumours treated with radiofrequency ablation.
Izaaryene J; Vidal V; Bartoli JM; Loundou A; Gaubert JY
Int J Hyperthermia; 2017 Sep; 33(6):653-658. PubMed ID: 28540783
[TBL] [Abstract][Full Text] [Related]
17. The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
Alafate A; Shinya T; Okumura Y; Sato S; Hiraki T; Ishii H; Gobara H; Kato K; Fujiwara T; Miyoshi S; Kaji M; Kanazawa S
Acta Med Okayama; 2013; 67(2):105-12. PubMed ID: 23603927
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.
Scheck J; Bruners P; Schindler D; Kuhl C; Isfort P
Korean J Radiol; 2018; 19(4):560-567. PubMed ID: 29962862
[TBL] [Abstract][Full Text] [Related]
19. EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success.
Crinò SF; D'Onofrio M; Bernardoni L; Frulloni L; Iannelli M; Malleo G; Paiella S; Larghi A; Gabbrielli A
J Gastrointestin Liver Dis; 2018 Mar; 27(1):67-72. PubMed ID: 29557417
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasound-guided radiofrequency ablation of unresectable pancreatic cancer with low ablation power and multiple applications: a preliminary study of 11 patients.
Wang J; Wang Y; Zhao Y; Wu X; Zhang M; Hou W; Chen Q; Cheng B
Ann Palliat Med; 2021 Feb; 10(2):1842-1850. PubMed ID: 33440967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
